Lower SARS-CoV-2 vaccine responses seen in patients with immune-mediated inflammatory diseasesMay 25, 2021COVID-19 UpdatesAnkylosing spondylitisLupus & Connective Tissue DiseasesPsoriatic ArthritisRheumatoid ArthritisSpondyloarthropathies
Multiple studies highlight pandemic’s impact on patients with rheumatic diseaseMay 6, 2021COVID-19 UpdatesRheumatoid ArthritisSpondyloarthropathiesPsoriatic ArthritisLupus & Connective Tissue DiseasesAnkylosing spondylitis
Line of therapy matters for assessing biologic’s serious infection risk in RAApril 27, 2021Rheumatoid Arthritis
Boosting the presence of darker skin in rheumatology educationApril 21, 2021Diversity in MedicineLupus & Connective Tissue DiseasesPsoriatic ArthritisPediatricsRheumatoid ArthritisSpondyloarthropathiesAnkylosing spondylitis
Most patients with chronic inflammatory diseases have sufficient response to COVID-19 vaccinationApril 20, 2021COVID-19 UpdatesAnkylosing spondylitisLupus & Connective Tissue DiseasesPsoriatic ArthritisRheumatoid ArthritisSpondyloarthropathies
Rheumatology clinics find success with smoking cessation referral programApril 8, 2021Rheumatoid ArthritisSpondyloarthropathiesPsoriatic ArthritisLupus & Connective Tissue DiseasesGoutAnkylosing spondylitis
Researchers stress importance of second COVID-19 vaccine dose for infliximab usersApril 6, 2021COVID-19 UpdatesRheumatoid ArthritisSpondyloarthropathiesPsoriatic ArthritisPediatricsAnkylosing spondylitis
COVID-19 vaccination in RMD patients: Safety data “reassuring”March 29, 2021COVID-19 UpdatesAnkylosing spondylitisGoutLupus & Connective Tissue DiseasesOrthopedicsOsteoarthritisOsteoporosis
FDA warning letters target OTC cannabidiol product claims for pain reliefMarch 25, 2021PainOsteoarthritisRheumatoid ArthritisSpondyloarthropathiesAnkylosing spondylitisPsoriatic Arthritis
RA expert updates latest pathologic findings from Accelerating Medicines PartnershipMarch 15, 2021Rheumatoid Arthritis
